Letter to the editor for the article "Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes"
- PMID: 37668720
- DOI: 10.1007/s00345-023-04575-w
Letter to the editor for the article "Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes"
Comment on
-
Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes.World J Urol. 2023 Aug;41(8):2185-2194. doi: 10.1007/s00345-023-04478-w. Epub 2023 Jun 22. World J Urol. 2023. PMID: 37347252 Free PMC article.
Similar articles
-
Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes.World J Urol. 2023 Aug;41(8):2185-2194. doi: 10.1007/s00345-023-04478-w. Epub 2023 Jun 22. World J Urol. 2023. PMID: 37347252 Free PMC article.
-
Pathological T0 Following Cisplatin-Based Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Network Meta-analysis.Clin Cancer Res. 2016 Mar 1;22(5):1086-94. doi: 10.1158/1078-0432.CCR-15-1208. Epub 2015 Oct 26. Clin Cancer Res. 2016. PMID: 26503947
-
Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.Eur Urol. 2015 Mar;67(3):402-22. doi: 10.1016/j.eururo.2014.12.008. Epub 2015 Jan 2. Eur Urol. 2015. PMID: 25560797
-
WITHDRAWN: Neoadjuvant cisplatin for advanced bladder cancer.Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD001426. doi: 10.1002/14651858.CD001426.pub2. Cochrane Database Syst Rev. 2011. PMID: 21678333 Free PMC article.
-
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.Eur Urol. 2012 Sep;62(3):523-33. doi: 10.1016/j.eururo.2012.05.048. Epub 2012 Jun 1. Eur Urol. 2012. PMID: 22677572
References
-
- Aydh A, Sari Motlagh R, Alamri A et al (2023) Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. World J Urol. https://doi.org/10.1007/s00345-023-04478-w - DOI - PubMed - PMC
-
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) (2022) Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane. www.training.cochrane.org/handbook
-
- Yuan Y, Liu L, Chen H et al (2016) Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell 29:711–722. https://doi.org/10.1016/j.ccell.2016.04.001 - DOI - PubMed - PMC
-
- Song Y, Qin C, Zhang C et al (2023) GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-023-04640-2 - DOI - PubMed - PMC
-
- Yanagisawa T, Kawada T, Quhal F et al (2023) Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis. World J Urol 41:1763–1774. https://doi.org/10.1007/s00345-023-04412-0 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical